These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26728532)

  • 21. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Lifestyle-related disease associated osteoporosis: Diabetes].
    Yamamoto M
    Clin Calcium; 2015 Sep; 25(9):1319-27. PubMed ID: 26320532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine as a Pathological Biomarker for Bone Disease.
    Behera J; Bala J; Nuru M; Tyagi SC; Tyagi N
    J Cell Physiol; 2017 Oct; 232(10):2704-2709. PubMed ID: 27859269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone quality].
    Saito M; Marumo K
    Nihon Rinsho; 2015 Oct; 73(10):1665-72. PubMed ID: 26529928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Update on fracture risk in life style-related diseases].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2014 Mar; 24(3):349-55. PubMed ID: 24576931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease.
    Allen MR; Newman CL; Chen N; Granke M; Nyman JS; Moe SM
    Osteoporos Int; 2015 Mar; 26(3):977-85. PubMed ID: 25466530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Daily practice using the guidelines for prevention and treatment of osteoporosis. How do we realize the bone quality in routine practice using Japanese guideline for osteoporosis prevention and treatment?].
    Saito M
    Clin Calcium; 2008 Aug; 18(8):1104-13. PubMed ID: 18677047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of bone quality with metabolic bone markers].
    Takeuchi Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():214-8. PubMed ID: 18161109
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determinants of bone quality and strength independent of bone remodeling].
    Saito M; Marumo K
    Clin Calcium; 2016 Jan; 26(1):29-41. PubMed ID: 26728528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes mellitus and osteoporosis. Predictive candidate markers for fracture risk in diabetic patients].
    Yamamoto M
    Clin Calcium; 2012 Sep; 22(9):1359-65. PubMed ID: 22932290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Roles of collagen enzymatic and advanced glycation end products associated crosslinking as a determinant of bone quality].
    Saito M; Marumo K
    Nihon Rinsho; 2011 Jul; 69(7):1189-97. PubMed ID: 21774356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of bone and joint disease - the present and future - . Risk and prevention/treatment of fractures associated with lifestyle-related diseases].
    Yamauchi M
    Clin Calcium; 2014 May; 24(5):733-42. PubMed ID: 24769685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of osteoporosis from the viewpoint of bone quality].
    Ito M
    Clin Calcium; 2006 Sep; 16(9):1457-61. PubMed ID: 16951468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
    Hansen S; Hauge EM; Beck Jensen JE; Brixen K
    J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does homocysteine contribute to bone disease in hyperparathyroidism?
    Alley RA; Chen EL; Beyer TD; Prinz RA
    Am J Surg; 2008 Mar; 195(3):374-7; discussion 377-8. PubMed ID: 18222411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary diseases and bone].
    Hirai T
    Clin Calcium; 2013 Feb; 23(2):237-42. PubMed ID: 23354091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and environmental variances of bone microarchitecture and bone remodeling markers: a twin study.
    Bjørnerem Å; Bui M; Wang X; Ghasem-Zadeh A; Hopper JL; Zebaze R; Seeman E
    J Bone Miner Res; 2015 Mar; 30(3):519-27. PubMed ID: 25407438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of antiresorptive therapy on the structural and material properties of bone strength].
    Kishimoto H
    Clin Calcium; 2016 Jan; 26(1):107-15. PubMed ID: 26728537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone.
    Herrmann M; Tami A; Wildemann B; Wolny M; Wagner A; Schorr H; Taban-Shomal O; Umanskaya N; Ross S; Garcia P; Hübner U; Herrmann W
    Bone; 2009 Mar; 44(3):467-75. PubMed ID: 19056526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
    Ikeda S; Akahoshi S; Sakai A; Nakamura T
    Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.